Gain Therapeutics Inc. (GANX)
NASDAQ · Healthcare
Gain Therapeutics Inc. Cash on Hand 2020–2023
Gain Therapeutics Inc. annual cash on hand history from 2020 to 2023. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Gain Therapeutics Inc. cash on hand as of December 31, 2023: 11.8M, a 61.32% increase year-over-year.
- Gain Therapeutics Inc. cash on hand for 2023 were 11.8M, a 61.32% increase from 2022.
- Gain Therapeutics Inc. cash on hand for 2022 were 7.3M, a 80.17% decrease from 2021.
- Gain Therapeutics Inc. cash on hand for 2021 were 36.9M, a 392.21% increase from 2020.
- Gain Therapeutics Inc. cash on hand for 2020 were 7.5M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Gain Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2023 | $12 |
| 2022 | $7 |
| 2021 | $37 |
| 2020 | $7 |
Gain Therapeutics Inc. Cash on Hand — FAQ
Gain Therapeutics Inc. (GANX) cash on hand over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GANX's cash on hand history?
The chart and table above show Gain Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.